Clinical Trial Update: Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Cosopt (dorzolamide/timolol) over 8 weeks in patients with open-angle glaucoma or ocular hypertension has completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Cosopt (dorzolamide/timolol)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2010-02-01